In:
American Journal of Public Health, American Public Health Association, Vol. 112, No. 1 ( 2022-01), p. 38-42
Abstract:
We conducted a community seroprevalence survey in Arizona, from September 12 to October 1, 2020, to determine the presence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We used the seroprevalence estimate to predict SARS-CoV-2 infections in the jurisdiction by applying the adjusted seroprevalence to the county’s population. The estimated community seroprevalence of SARS-CoV-2 infections was 4.3 times greater (95% confidence interval = 2.2, 7.5) than the number of reported cases. Field surveys with representative sampling provide data that may help fill in gaps in traditional public health reporting. (Am J Public Health. 2022;112(1):38–42. https://doi.org/10.2105/AJPH.2021.306568 )
Type of Medium:
Online Resource
ISSN:
0090-0036
,
1541-0048
DOI:
10.2105/AJPH.2021.306568
Language:
English
Publisher:
American Public Health Association
Publication Date:
2022
detail.hit.zdb_id:
2054583-6
